These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 38939068)

  • 1. Consumption of proton pump inhibitors in outpatients of Gastroenterology Clinics in Khyber Pakhtunkhwa: evidence of inexpedient use.
    Ashfaq M; Abid SMA; Khan Q; Sharif MJH; Haroon MZ; Khan AN; Alkahraman YM
    Prz Gastroenterol; 2024; 19(2):159-164. PubMed ID: 38939068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term proton pump inhibitors therapy and prevalence of hyperprolactinaemia: A cross-sectional study in outpatient gastroenterology clinics.
    Ashfaq M; Khan AN; Alkahraman YM; Haroon MZ
    J Pak Med Assoc; 2024 Jun; 74(6):1067-1073. PubMed ID: 38948973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proton pump inhibitor utilisation and potentially inappropriate prescribing analysis: insights from a single-centred retrospective study.
    Liu Y; Zhu X; Li R; Zhang J; Zhang F
    BMJ Open; 2020 Nov; 10(11):e040473. PubMed ID: 33243802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Five-year examination of utilization and drug cost outcomes associated with benefit design changes including reference pricing for proton pump inhibitors in a state employee health plan.
    Johnson JT; Neill KK; Davis DA
    J Manag Care Pharm; 2011 Apr; 17(3):200-12. PubMed ID: 21434697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proton-pump inhibitor utilization associated with the change to nonpreferred formulary status for esomeprazole in the TRICARE formulary.
    Linton A; Bacon T; Peterson M
    J Manag Care Pharm; 2009; 15(1):42-54. PubMed ID: 19125549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-Term Proton Pump Inhibitor Therapy and its Effect on Endocrine Hormones in Selected Patient Population.
    Ashfaq M; Khan Q; Haroon MZ; Abid SMA; Sharif MJH; Alkahraman YM
    Horm Metab Res; 2023 Mar; 55(3):205-211. PubMed ID: 36626934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolution of the consumption trend of proton pump inhibitors in the Lleida Health Region between 2002 and 2015.
    Torres-Bondia F; de Batlle J; Galván L; Buti M; Barbé F; Piñol-Ripoll G
    BMC Public Health; 2022 Apr; 22(1):818. PubMed ID: 35461252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medical and non-medical predictors of initiating long-term use of proton pump inhibitors: a nationwide cohort study of first-time users during a 10-year period.
    Haastrup PF; Paulsen MS; Christensen RD; Søndergaard J; Hansen JM; Jarbøl DE
    Aliment Pharmacol Ther; 2016 Jul; 44(1):78-87. PubMed ID: 27137875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Appropriateness of proton pump inhibitors treatment in clinical practice: Prospective evaluation in outpatients and perspective assessment of drug optimisation.
    Giannini EG; Crespi M; Djahandideh A; Demarzo MG; Moscatelli A; Bodini G; Furnari M; Marabotto E; Plaz Torres MC; Zentilin P; Savarino V
    Dig Liver Dis; 2020 Aug; 52(8):862-868. PubMed ID: 32505566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Empirical treatment of outpatients with gastroesophageal reflux disease with proton pump inhibitors: A survey of Chinese patients (the ENLIGHT Study).
    Lu B; Zhang L; Wang J; Wang B; Zou X; Fei G; Chen D; Wang X; Wu B; Zou D
    J Gastroenterol Hepatol; 2018 Oct; 33(10):1722-1727. PubMed ID: 29575167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of proton pump inhibitors in adults in France: a nationwide drug utilization study.
    Lassalle M; Le Tri T; Bardou M; Biour M; Kirchgesner J; Rouby F; Dumarcet N; Zureik M; Dray-Spira R
    Eur J Clin Pharmacol; 2020 Mar; 76(3):449-457. PubMed ID: 31838548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding.
    Leontiadis GI; Sreedharan A; Dorward S; Barton P; Delaney B; Howden CW; Orhewere M; Gisbert J; Sharma VK; Rostom A; Moayyedi P; Forman D
    Health Technol Assess; 2007 Dec; 11(51):iii-iv, 1-164. PubMed ID: 18021578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proton pump inhibitors and risk of hip fracture: a meta-analysis of observational studies.
    Poly TN; Islam MM; Yang HC; Wu CC; Li YJ
    Osteoporos Int; 2019 Jan; 30(1):103-114. PubMed ID: 30539272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prescribing Patterns of Proton Pump Inhibitors in Germany: A Retrospective Study Including 472 146 Patients.
    Plehhova K; Haering M; Wray J; Coyle C; Ibáñez E; Kostev K
    J Prim Care Community Health; 2023; 14():21501319231221002. PubMed ID: 38142444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of long-term proton pump inhibitor use on sexual hormones and sexual and reproductive health in female patients.
    Ashfaq M; Khan Q; Haroon MZ; Abid SMA; Sharif MJH; Alkahraman YMSA
    Endocrine; 2024 Feb; 83(2):494-501. PubMed ID: 37914918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of proton pump inhibitors on the antiplatelet effects of clopidogrel.
    Sibbing D; Morath T; Stegherr J; Braun S; Vogt W; Hadamitzky M; Schömig A; Kastrati A; von Beckerath N
    Thromb Haemost; 2009 Apr; 101(4):714-9. PubMed ID: 19350116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns of proton pump inhibitor utilization in gastroesophageal reflux disease and the effect of restrictions on reimbursement: a nationwide prescription database study.
    Jonasson C; Tvete IF; Hatlebakk JG
    Scand J Gastroenterol; 2013 Sep; 48(9):1010-7. PubMed ID: 23859491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term use of proton-pump inhibitors: whole-of-population patterns in Australia 2013-2016.
    Daniels B; Pearson SA; Buckley NA; Bruno C; Zoega H
    Therap Adv Gastroenterol; 2020; 13():1756284820913743. PubMed ID: 32218806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myopathy including polymyositis: a likely class adverse effect of proton pump inhibitors?
    Clark DW; Strandell J
    Eur J Clin Pharmacol; 2006 Jun; 62(6):473-9. PubMed ID: 16758264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association Between Proton Pump Inhibitors and Microscopic Colitis.
    Law EH; Badowski M; Hung YT; Weems K; Sanchez A; Lee TA
    Ann Pharmacother; 2017 Mar; 51(3):253-263. PubMed ID: 27733667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.